In this resource, we provide an extensive guide enabling users to apply the most widely-used synthetic strategies for SPPS, and helpful hints to avoid some of the obstacles that often lead to expensive mistakes and/or poor synthesis yield.
Read moreA practical CSBio selection guide for choosing the right automated peptide synthesizer for research, process development, pilot production, GMP manufacturing, and commercial scale peptide production.
Read moreHow temperature and coupling time influence reaction kinetics, side reactions, and crude purity in research-scale peptide synthesis. Explore model peptide results, coupling chemistries, and the role of solvent preheating.
Read moreHighlights from the 21st Annual Peptide Therapeutics Symposium, covering multi-receptor therapies, AI-driven peptide design, clinical development, delivery, and manufacturing.
Read moreThe third quarter of 2026 brought notable momentum to peptide drug development, marked by an influx of oral peptide drug approvals, novel inhaled peptide delivery models, exciting advances in personalized cancer vaccines, and a welcome shift of attention toward women's health.
Read moreThe second quarter of 2026 has been a bustling period for peptide drug development, with continued growth in obesity and metabolic health and new developments in oncology and pain management. We’ve highlighted advancements spanning Phase 2/3 data in chronic weight management as well as targeted peptide treatments tackling oncology, rare bone disorders, and chronic inflammation.
Read moreCSBio is a leading peptide instrumentation manufacturing company located in Silicon Valley, California.
CSBio provides research scale peptide synthesizers, pilot scale peptide synthesizers, commercial scale peptide synthesizers, and DNA/RNA oligonucleotide synthesizers.
